Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
epoetin (Epogen) (1 trial)
Ataxia (Phase 2)
Cerebellar Ataxia (Phase 2)
Friedreich Ataxia (Phase 2)
Trials (1 total)
Trial APIs (1 total)